Cost–consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: The potential impact of different cross-protection profiles von Capri, S, Gasparini, R, Panatto, D, Demarteau, N

Volltext

Potential Risk-Sharing Agreements for Vaccines von Terlinden, A, Ethgen, O, Demarteau, N, Curran, D

Volltext

Potential Monetary Value of Human Papillomavirus Vaccination on Human Papillomavirus-Related Cancers and Genital Warts in the United Kingdom von Van Kriekinge, G, Starkie-Camejo, H, Li, X, Demarteau, N

Volltext

Response to: "The use of an “old-fashioned method” to assess the clinical and economic impact of a HPV vaccination program" von Capri, S, Gasparini, R, Panatto, D, Demarteau, N

Volltext

How Do Decision Makers in Europe Value Other Economic Evaluation Tools Than Cost-Effectiveness Analysis for Vaccines? von Höhne, J.M, Demarteau, N, Saka, Ö, Standaert, B, Kleintjens, J

Volltext

PIN39 A Cost Consequence Analysis of a Quadrivalent Meningococcal Vaccine (MenACWY-TT) in Canada von Cognet, M, Jiang, Y, Parker, M, Demarteau, N, Bauch, C.T

Volltext

Costs associated with persistent allergic rhinitis are reduced by levocetirizine von Bousquet, J., Demarteau, N., Mullol, J., Akker‐van Marle, M. E., Van Ganse, E., Bachert, C.

Volltext

PCN1 Selecting a Mix of Prevention Strategies Against Cervical Cancer for Maximum Efficiency with an Optimisation Program von Demarteau, N, Gomez, J.A, Lorenzato, F, Standaert, B

Volltext

P926 Modelling the impact of different vaccine profiles on the cost-effectiveness of HPV vaccination in the Chilean setting von Demarteau, N., Suarez, E., Gomez, J., Standaert, B.

Volltext

Budget Impact Associated With The Implementation Of A Dtpa-Ipv-Hepb/Hib Hexa Vaccination Program In Slovenia von Demarteau, N, Geets, R, Plevnik Kapun, A

Volltext

PIN18 - Budget Impact Associated With The Implementation Of A Dtpa-Ipv-Hepb/Hib Hexa Vaccination Program In Slovenia von Demarteau, N, Geets, R, Plevnik Kapun, A

Volltext

PCN60 Economic Evaluation of Vaccination Against Cervical Cancer in the Moscow Region von Shakhanina, I, Namazova-baranova, L, Krasnopolskiy, V.I, Zarochentseva, N.V, Kozachenko, V.P, Demarteau, N, Shchurov, D

Volltext

Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium von Demarteau, Nadia, Van Kriekinge, Georges, Simon, Philippe

Volltext

HSD27 Constrained Optimization Model to Estimate Best Booster Allocation Strategy to Minimize Hospital Bed-Days Under a Fixed Healthcare Budget von Kapoor, R, Standaert, B, Nolan, T, Pezalla, EJ, Arnetorp, S, Bergenheim, K, Bungey, G, Darroch-Thompson, D, Gani, R, Meeraus, W, Okumura, L, Sutton, K, Tichy, E, Yokota, R, Demarteau, N

Volltext

PIN68 - How Do Decision Makers in Europe Value Other Economic Evaluation Tools Than Cost-Effectiveness Analysis for Vaccines? von Höhne, J.M., Demarteau, N., Saka, Ö., Standaert, B., Kleintjens, J.

Volltext

PIN35 - Potential Risk-Sharing Agreements for Vaccines von Terlinden, A., Ethgen, O., Demarteau, N., Curran, D.

Volltext

PCN113 - Potential Monetary Value of Human Papillomavirus Vaccination on Human Papillomavirus-Related Cancers and Genital Warts in the United Kingdom von Van Kriekinge, G., Starkie-Camejo, H., Li, X., Demarteau, N.

Volltext

VA4 COMPARING COST-EFFECTIVENESS RESULTS: OF A CROSS-SECTIONAL POPULATION MODEL WITH A COHORT MODEL: THE APPLICATION TO PNEUMOCOCCAL CONJUGATE VACCINATION von Demarteau, N, Standaert, B

Volltext

PCN15 ESTIMATING THE COST EFFECTIVENESS OF PROPHYLACTIC CERVICAL CANCERVACCINATION IN IRELAND USING A MATHEMATICAL MODEL von Redmond, S, Demarteau, N

Volltext

PIH2 IMPACT OF HPV VACCINATION ON CERVICAL CANCER IN ASIA: RESULTS OF A STATIC MODEL von Demarteau, N, Van Kriekinge, G, Castellsagué, X

Volltext